Please login to the form below

Not currently logged in
Email:
Password:

FDA conforms to Plan B ruling

The FDA has announced it will not appeal against a federal court's ruling to allow the morning-after pill, Plan B, to be marketed in the US to girls aged 17 and over

The US Food and Drug Administration (FDA) has announced it will not appeal against a federal court's ruling to allow the morning-after pill, Plan B, to be marketed in the US to girls aged 17 and over.

In March 2009, Judge Edward Korman ruled that the FDA decision had been made on political grounds and was not consistent with the scientific findings made in 2005 by the Centre for Drug Evaluation and Research. 

The FDA has since notified Duramed Research, the manufacturers of the emergency contraceptive, that upon submission and approval of an appropriate application, Plan B can be marketed for use by girls over 17 years old without a prescription.

Duramed Research is a subsidiary of Teva Pharmaceuticals.

23rd April 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

Improving Outcomes in the Treatment of Opioid Dependence Highlights Report
The 16th annual ‘Improving Outcomes in the Treatment of Opioid Dependence’ (IOTOD)conference took place at the Hilton Madrid Airport hotel on 15–16 May 2018....
Londonvelophobia (fear of cycling in London) – debunked
...
How Helpful are Simple Health Messages?
...

Infographics